Carcinogenesis, Vol. 22, No. 2, 321-328,
February 2001
© 2001 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Resveratrol analog, 3,4,5,4'-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts
1 Department of Chemistry,
2 Center for Advanced Food Technology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8087, USA and
3 New Jersey Cancer Institute, New Brunswick, NJ 08901, USA
Resveratrol, a trihydroxystilbene found in grapes and other plants, has been shown to be active in inhibiting multistage carcinogenesis. Using resveratrol as a prototype, we have synthesized a number of polyhydroxy- and polymethoxy-stilbenes and tested their anti-proliferative effect in normal and transformed human cells. Here we show that one of the resveratrol analogs, 3,4,5,4'-tetrahydroxystilbene (R-4), specifically inhibited the growth of SV40 virally transformed WI38 cells (WI38VA) at 10 µM, but had no effect on normal WI38 cells at even higher concentrations. R-4 also prominently induced apoptosis in WI38VA cells, but not in WI38 cells. RNase protection assay showed that R-4 significantly induced the expression of p53, GADD45 and Bax genes and concomitantly suppressed the expression of bcl-2 gene in WI38VA, but not in WI38 cells. A large increase in p53 DNA binding activity and the presence of p53 in the Bax promoter binding complex suggested that p53 was responsible for the Bax gene expression induced by R-4 in transformed cells. Within 4 h of treatment with R-4, the Bax to bcl-2 protein ratio in WI38 and WI38VA cells was, respectively, 0.1 and 105, a difference of three orders of magnitude. While R-4 prominently induced the p53/Bax pro-apoptotic genes, it also concomitantly suppressed the expression of Cox-2 in WI38VA cells. Taken together, our study suggests that the induction of p53 gene by R-4 in transformed cells may play a key role in the differential growth inhibition and apoptosis of transformed cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-M. SU, P. LIN, C.-K. WANG, and H. CHANG Overexpression of Cytochrome P450 1B1 in Advanced Non-small Cell Lung Cancer: A Potential Therapeutic Target Anticancer Res, February 1, 2009; 29(2): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, et al. Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells J. Biol. Chem., October 17, 2003; 278(42): 41482 - 41490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakazawa, T. Kamijo, K. Koike, and T. Noda ARF Tumor Suppressor Induces Mitochondria-dependent Apoptosis by Modulation of Mitochondrial Bcl-2 Family Proteins J. Biol. Chem., July 18, 2003; 278(30): 27888 - 27895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. G. Li, T. Hong, Y. Shimada, I. Komoto, A. Kawabe, Y. Ding, J. Kaganoi, Y. Hashimoto, and M. Imamura Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol Carcinogenesis, September 1, 2002; 23(9): 1531 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. H. Chang, J. Chen, and W. B. K. Lee Differential Inhibition and Inactivation of Human CYP1 Enzymes by trans-Resveratrol: Evidence for Mechanism-Based Inactivation of CYP1A2 J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 874 - 882. [Abstract] [Full Text] [PDF]
|
|